Cabaletta Bio (NasdaqGS:CABA) 2026 Conference Transcript
Cabaletta Bio (NasdaqGS:CABA) 2026 Conference February 12, 2026 09:30 AM ET Company ParticipantsDavid Chang - CMOSteve Gavel - Chief Commercial OfficerSteven Nichtberger - President, CEO and Co-FounderYatin Suneja - Senior Managing DirectorConference Call ParticipantsDalma Caiati - Biotech AnalystYatin SunejaAll right, we will go ahead and get started. Good morning, everyone. Welcome to Guggenheim Emerging Outlook Biotech Summit 2026. My name is Yatin Suneja, one of the biotech analysts here at the firm, jo ...